相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。IL-1R1 Signaling Facilitates Munro's Microabscess Formation in Psoriasiform Imiquimod-Induced Skin Inflammation
Mireia Uribe-Herranz et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Caspase-14-Deficient Mice Are More Prone to the Development of Parakeratosis
Esther Hoste et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling
Khalifa El Malki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Langerinneg conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice
Christian Wohn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Aldara activates TLR7-independent immune defence
Anne Walter et al.
NATURE COMMUNICATIONS (2013)
Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice
Stanislav Pantelyushin et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation
Chung-Ching Chu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice
Astrid B. Van Belle et al.
JOURNAL OF IMMUNOLOGY (2012)
The Multitasking Organ: Recent Insights into Skin Immune Function
Paola Di Meglio et al.
IMMUNITY (2011)
Tumor Necrosis Factor α-Mediated Induction of Interleukin 17C in Human Keratinocytes Is Controlled by Nuclear Factor κB
Claus Johansen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
Vladimir Ramirez-Carrozzi et al.
NATURE IMMUNOLOGY (2011)
Mutual Antagonism of T Cells Causing Psoriasis and Atopic Eczema
Stefanie Eyerich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Genome-Wide Expression Profiling of Five Mouse Models Identifies Similarities and Differences with Human Psoriasis
William R. Swindell et al.
PLOS ONE (2011)
Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy
C. Johansen et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
New Insights in the Immunologic Basis of Psoriasis
Kristine E. Nograles et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2010)
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
Leslie van der Fits et al.
JOURNAL OF IMMUNOLOGY (2009)
Resident and Inflammatory'' Dendritic Cells in Human Skin
Lisa C. Zaba et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Antonella Di Cesare et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Thomas Duhen et al.
NATURE IMMUNOLOGY (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Psoriasis Induced or Aggravated by Drugs
Franco Rongioletti et al.
JOURNAL OF RHEUMATOLOGY (2009)
T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis
Andrew Blauvelt
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
Michelle A. Lowes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Imiquimod:: mode of action
M. P. Schoen et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
A role for T cell-derived interleukin 22 in psoriatic skin inflammation
K. Boniface et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Mouse models of psoriasis
Johann E. Gudjonsson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs
Stefanie Kunz et al.
EXPERIMENTAL DERMATOLOGY (2006)
Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod
P. A. Fanti et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)
Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas
N Rajan et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis
K Otkjaer et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment
M Urosevic et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
FO Nestle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Dysfunctional blood and target tissue CD4(+)CD25(high) regulatory T cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T cell proliferation
H Sugiyama et al.
JOURNAL OF IMMUNOLOGY (2005)
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris
E Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6
T Kawai et al.
NATURE IMMUNOLOGY (2004)
Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod
F Palamara et al.
JOURNAL OF IMMUNOLOGY (2004)
Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors
M Gilliet et al.
ARCHIVES OF DERMATOLOGY (2004)
Plasmacytoid dendritic cells:: A new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases
A Wollenberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential
MA Stanley
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2002)